Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 61-80 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 61 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Isar Aerospace has the clearest recent opportunity setup in this screen: a June 2026 article summary says it raised €270 million ($312 million), has total capital near €1 billion excluding ESA support, and scheduled a Spectrum launch window for June 15-21 from Norway. If execution succeeds, the article frames it as a milestone for European commercial launch capability. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 62 | K2 Space mediummedium | Opp 5 Risk 2 | Thesis: K2 Space has a credible 1 year+ opportunity setup because a dated June 11, 2026 article says it landed a key supplier role in the U.S. Space Force's next-generation military communications network and will provide the satellite platform for SES's PTS-G program, which could support longer-cycle strategic relevance and follow-on demand if execution proceeds. Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones. Evidence
Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation. |
| 63 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Millennium Space Systems has a positive long-horizon signal from being named among companies awarded Space Force Andromeda contracts tied to geosynchronous reconnaissance and surveillance satellites, indicating program access in a strategically relevant segment. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 64 | Northwood Space mediumweak | Opp 5 Risk 2 | Thesis: Northwood Space has the clearest reviewed sources-supported opportunity among the smaller private names because the reviewed sources directly says it has a Space Force contract and a factory tied to optical ground stations, which supports durable government-linked space infrastructure relevance over a 1 year+ horizon. Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources. Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction. |
| 65 | Orion Space Solutions mediummedium | Opp 5 Risk 2 | Thesis: Orion Space Solutions has meaningful contract-backed business activity within the recent evidence window, with initial contracts over $24 million, over 25 payloads, multi-year execution scope, and total potential value above $100 million if batch deliveries complete. Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon Evidence
Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation. |
| 66 | OroraTech mediummedium | Opp 5 Risk 2 | Thesis: OroraTech shows moderate long-horizon opportunity because a dated May 4, 2026 article reports deployment of four proprietary wildfire-detection satellites for Greece as part of an operational sovereign system, suggesting real product deployment, country-level adoption, and vertically integrated execution from satellites through data processing. Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists Evidence
Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk. |
| 67 | RapidTek lowweak | Opp 5 Risk 3 | Thesis: Relatively better opportunity within these reviewed sources: the membership rationale says RapidTek successfully connected its Black Kite-2 8U CubeSat with ground stations and aims for a LEO IoT network. That is a concrete technical milestone with a plausible 1 year+ commercialization pathway if network development continues. Why now: Why now is the reported successful satellite-ground connection and stated LEO IoT ambition referenced in article ID, though the reviewed sources does not include the article or exact timing details. Caveats: The technical milestone is described only in membership rationale, not available direct evidence. Article ID has no in the reviewed sources. Technical connectivity milestone is weaker than contracted commercial deployment. |
| 68 | Skyroot Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Skyroot has a credible long-horizon opportunity case from recent financing and launcher milestone positioning: Fortune India says it raised nearly $60 million at a $1.1 billion pre-money valuation and is preparing for the maiden flight of Vikram-1, its orbital launch vehicle. Why now: The relevant dated development is the reported financing on May 7, 2026 alongside the stated approach to the Vikram-1 maiden flight, which fits a 1 year+ thesis if execution progresses. Evidence
Caveats: Support is supporting article context only; the reviewed sources have no direct positive events available for Skyroot. Same-article repeated context rows are not independent confirmation. |
| 69 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Spark Space has a credible speculative opportunity because supporting article context says it tested an engine and raised funds for an electric-pump rocket, which are relevant proof points for an early launch company over a 1 year+ horizon. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 70 | Stellar Alpina AG lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources' membership rationale states Stellar Alpina is a Swiss space startup that raised CHF 3.5M pre-seed and is developing rotating detonation rocket engines for in-space mobility. For a 1 year+ horizon, recent financing plus differentiated propulsion development creates meaningful upside optionality. Why now: Why now is relatively better than peers because the rationale includes a recent capital raise and a specific product focus, both of which can influence a 1 year+ strategic trajectory, though no direct dated evidence are available to verify recency sequencing. Caveats: Membership rationale cites article IDs: and: but no are present. The reviewed sources contain no direct positive or negative evidence arrays despite the financing statement in the rationale. Early-stage propulsion development is inherently high-uncertainty, but that is inferred from stage and product type, not from a available adverse article. |
| 71 | The Exploration Company lowweak | Opp 5 Risk 2 | Thesis: Moderate long-horizon opportunity based on article-context evidence that the company won an ESA cargo return service contract and was ranked first in the competition, which suggests external validation and potential programmatic traction if still current. Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious. Evidence
Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence. |
| 72 | Tomorrow.io lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale states Tomorrow.io raised an additional $35M, bringing its Series F to $210M, for the DeepSky AI-native satellite constellation, which supports a moderate long-horizon opportunity thesis around financing-backed constellation buildout and commercialization. Why now: The 'why now' is the capital raise described in the reviewed sources' membership rationale via article: but the ranking payload does not include the article or a richer reviewed evidence row, so recency and detail are only partially grounded. Evidence
Caveats: The reviewed sources does not provide the article for the cited membership-support article. This is mainly a financing-backed opportunity thesis, not a contract- or revenue-backed one in these reviewed sources. |
| 73 | Transcelestial lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes Transcelestial as a private lasercom startup aiming for a LEO constellation and having a partnership to advance optical communications architecture in LEO. If current, that supports a durable 1 year+ opportunity tied to optical communications buildout. Why now: Why now is only moderate because the membership rationale references support references including, and: but the reviewed sources does not provide or article summaries for them. Without visible dated article detail, the near-current business state cannot be confirmed. Caveats: Important claims appear only in the membership rationale; no -bearing direct evidence is exposed. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 74 | Umbra mediummedium | Opp 5 Risk 2 | Thesis: Umbra has a moderate long-horizon opportunity case because a dated June 22, 2026 article describes it as a U.S. commercial space company developing and operating a SAR satellite constellation that delivers rapid, regular, high-resolution data to public and private customers, suggesting an already-operational capability base that could support durable growth over a 1 year+ horizon. Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong. Evidence
Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring. |
| 75 | Unastella lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources say Unastella is a South Korean startup developing small satellite launch vehicles, has raised a Series B, and successfully launched Una Express-I. That combination of financing and a successful launch milestone is one of the clearer long-horizon opportunity setups in this screen, if current. Why now: Why now is relatively stronger because the rationale includes both funding and a technical milestone, which are durable indicators for a 1 year+ horizon, though exact dates and chronology cannot be checked from the reviewed sources' empty post-recent evidence window evidence tables. Caveats: Membership rationale cites article IDs: and: but no are given. No direct events or summaries are available after recent evidence window, so success claims cannot be quoted from the reviewed sources. Opportunity and risk both reflect a capital-intensive launch model with limited reviewed sources verification. |
| 76 | Univity lowweak | Opp 5 Risk 4 | Thesis: Best-supported opportunity in this sparse batch: the reviewed sources membership rationale says Univity raised $32M to build a European satellite network rivaling Starlink, which is a direct financing-and-buildout claim that can matter over a 1 year+ horizon if execution continues. Why now: Why now is the claimed funding event and network build plan referenced in article ID: but the reviewed sources does not provide the article or detailed timestamp, so recency is only partially grounded. Caveats: The key claim comes from membership rationale rather than available direct evidence. Article ID: is referenced without a. No evidence of downstream execution, contracts, launches, or adoption is present. |
| 77 | Vantor lowweak | Opp 5 Risk 4 | Thesis: The reviewed sources membership rationale describes potentially material traction: Vantor is described as having won a $70M NGA GEOINT platform contract, additional NGA Luno B contracts for orbital intelligence and AI change detection, and plans satellite constellation expansion, which would support a multi-quarter opportunity thesis if confirmed in article detail. Why now: Why now is only moderate because the membership rationale references significant contracts via support references including: but the reviewed sources provide no or representative article detail for citation-quality corroboration. The forecast horizon of 1 year+ could fit contract conversion and constellation expansion if current, but recency cannot be validated from visible article rows. Caveats: The contract and expansion claims appear only in membership rationale text; no representative article with is included. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 78 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Albedo has the clearest dated recency in the reviewed sources: an external article states the company announced plans on April 9 to send its second spacecraft and is preparing a second VLEO mission for 2027 launch, which suggests continued program progression over a 1 year+ horizon Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 79 | Apogeo Space lowweak | Opp 4 Risk 2 | Thesis: Apogeo Space has moderate long-horizon opportunity on reviewed sources evidence because it is described as having a ground-station integration agreement and technical collaboration on CubeSat platforms, payloads, and joint missions, indicating active ecosystem positioning in space infrastructure and services. Why now: The reviewed sources' membership rationale cites article: for the integration agreement and technical collaboration, but no article or direct evidence are included. Caveats: Evidence is thin and article-level details are missing. Collaboration and integration agreements are weaker than revenue-bearing customer wins. Single-article support limits conviction. |
| 80 | Astranis lowmedium | Opp 4 Risk 2 | Thesis: Astranis has recent supporting article context indicating both contract relevance and financing support: it was included among companies awarded Space Force Andromeda contracts on April 8, 2026 and was reported to have raised a $300 million Series E on June 19, 2026, which supports a longer-horizon capacity and program participation thesis. Why now: Recent dated context within the 90-day recent evidence window points to fresh financing and government program inclusion, both relevant for a 1 year+ horizon: Andromeda context on April 8, 2026 and funding context on June 19, 2026 Evidence
Caveats: Evidence is mainly supporting article context, which is weaker than direct event/fact evidence. An older 2025 article about a 2027 transportation deal exists, but it is outside the recent evidence window and not used as current proof. |
Risk view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Interlune lowweak | Opp 5 Risk 3 | Thesis: The company also carries execution risk because the reviewed sources provide no further retained evidence on milestone completion, follow-on awards, commercialization timing, or technical results. A single contract supports relevance but does not prove scalable economics. Why now: The key 'why now' is the cited NASA contract in article: but the reviewed sources does not include the article summary or, so exact date and latest status are not visible here. Caveats: Opportunity case relies on membership rationale rather than included direct article evidence. A $6.9M contract is positive validation, but contract size alone may not be enough to de-risk a lunar-resource business. No negative evidence is provided, so risk mostly reflects execution uncertainty. |
| 82 | IonQ lowweak | Opp 3 Risk 3 | Thesis: Risk stems from thesis leakage: the reviewed sources frames IonQ primarily as parent/acquirer, while the strongest space-specific evidence appears to sit at subsidiary level, so investors could overstate IonQ's direct space-business impact based on insufficient company-specific proof. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 83 | Iridium Communications Inc. lowmedium | Opp 5 Risk 3 | Thesis: Risk is moderate-low because there is no direct adverse evidence, but the reviewed sources lack recent company-specific contract, financing, or product milestone catalysts, so the case depends more on strategic position than on fresh business acceleration. Why now: The current support is an April 3, 2026 article-level overview of Iridium’s constellation and service footprint rather than a new event, so timing fit is only medium. Evidence
Caveats: Evidence is supporting article context, not a fresh contract or earnings-linked milestone. |
| 84 | Kepler mediummedium | Opp 6 Risk 3 | Thesis: Risk remains moderate because the evidence is primarily a company-source article and supporting article context rather than independent dated event evidence. The reviewed sources show no adverse developments, but also limited third-party confirmation. Why now: The latest visible evidence is dated June 23, 2026, making the milestone recent within the 90-day recent evidence window. The article explicitly frames this as the beginning of an operational network, which is more relevant to a 1 year+ horizon than a short-lived announcement. Evidence
Caveats: Primary evidence is from Kepler's own site. No direct contract, revenue, or financing detail is provided in the visible evidence. Same article appears in both representative and weak-context forms, which is not independent confirmation. |
| 85 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: There is no direct negative evidence available. The main risk is that the business description is broad but unsupported by current, citable post-recent evidence window evidence, leaving commercialization and scale uncertain. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 86 | L3Harris Technologies mediummedium | Opp 6 Risk 3 | Thesis: Risk is lower than many peers in these reviewed sources because there is no cited direct adverse evidence, but the ranking is capped by limited fresh company-specific evidence within the 90-day window and reliance on supporting article context rather than detailed award economics attributable specifically to L3Harris. Why now: The recent timing anchor is the April 8, 2026 Andromeda article. Older 2020 MOSSAIC history exists in the reviewed sources but should not drive the current timing view because it is outside the recent evidence window and materially older than the current contract context. Evidence
Caveats: Current opportunity case depends on supporting article context rather than available direct positive events. The reviewed sources includes an older 2020 contract article, but that is not recent support for 'why now'. |
| 87 | Loft Orbital mediummedium | Opp 7 Risk 3 | Thesis: Risk exists because the positive case is largely supporting article context from external supporting source sources rather than direct dated events in the reviewed sources, and execution remains significant given a 10-satellite constellation deployment and launch timeline. But there is no retained material adverse evidence. Why now: Why now is credible for a 1 year+ horizon because several dated articles from 2026 establish a recent contract win and near-forward deployment timeline: Loft announced on April 30, 2026 a multi-year CNES contract worth up to tens of millions of euros with first satellite scheduled to launch in Q4 2026. Via Satellite on May 1, 2026 described a 10-satellite EO constellation under that contract. SpaceNews on May 5, 2026 said Loft is expanding into 'full-service constellation deals'. Evidence
Caveats: Most retained support is supporting article context, which the reviewed sources treats as bounded context and weaker than direct dated event/fact evidence. Several favorable funding articles for Loft are dated January 2025 and were dropped by the 90-day recent evidence window, so they should not drive the current score. Execution risk remains around deploying the constellation and meeting the stated 2026 launch timing. |
| 88 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because the available evidence is entirely undated external article context, making recency and state-of-business uncertain. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 89 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Risk remains moderate because the reviewed sources supplies no available positive evidence after recent evidence window to confirm timing, contract status, or deployment progress; mission-heavy lunar communications programs can be timing-sensitive, but these reviewed sources gives no adverse proof either. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 90 | Muon Space lowweak | Opp 3 Risk 3 | Thesis: Risk is balanced with opportunity because the available evidence is mostly weak supporting article context rather than direct contract, financing, or milestone evidence, leaving business traction and near-medium term scaling uncertain. Why now: The most recent dated context is a May 22, 2026 job posting indicating contracting and legal operations needs, which may imply organizational buildout but is weak evidence for a major catalyst. Evidence
Caveats: The reviewed sources contain no direct positive or negative company-specific events. The May 22, 2026 job posting is operational context, not proof of revenue or contracts. Citation |
| 91 | NordSpace Corp. lowweak | Opp 3 Risk 3 | Thesis: No direct adverse evidence is available, but development-stage rocket businesses carry obvious execution dependency; in these reviewed sources that risk cannot be upgraded to high because the evidence does not show a specific setback, only insufficient current confirmation. Why now: The only directional clue is the membership-support article reference: but the reviewed sources includes no, no summary, and no available post-recent evidence window evidence, so timing and durability are uncertain. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Opportunity case relies on generic funding support mention without current milestone evidence. |
| 92 | Northrop Grumman Corp mediumstrong | Opp 8 Risk 3 | Thesis: Risk is present but comparatively modest in the reviewed sources because no material adverse event is cited. The main risk is that the evidence is largely supporting article context and program participation, so exact economic contribution, timing, and competitive share are not fully established here. Why now: The setup is current and cumulative: April 8, 2026 Andromeda participation, June 1, 2026 Golden Dome interceptor partnership, and June 22, 2026 award of a $398M protected satcom contract all fall within the 90-day recent evidence window and point to sustained momentum. Evidence
Caveats: The reviewed sources does not provide direct business impact breakdowns beyond the $398M contract article. Some support is supporting article context rather than dated events. |
| 93 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: Risk is moderate because evidence coverage is very thin, and the reviewed sources offers mainly context that the company planned to go public via SPAC, without stronger direct proof on operational milestones or contract conversion in this company row. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 94 | Open Cosmos mediummedium | Opp 7 Risk 3 | Thesis: Risk is present but not strongly evidenced as negative news. The main risks are that the evidence is supporting article context rather than direct events, and one supporting item concerns spacecraft supply to a military mission rather than direct revenue or contract award to Open Cosmos. Why now: The timing is favorable for a 1 year+ horizon because the latest dated evidence on June 17, 2026 indicates market entry and operation of the first telecom satellites, which can matter over a multi-quarter rollout period. A prior April 8, 2026 article also shows Open Cosmos spacecraft being used in the Orpheus UK military mission, adding defense-adjacent relevance. These dates are source dates extracted from the article summaries. Evidence
Caveats: Evidence is external article context and weak-context rows, not direct positive events. Same-article repeated rows are not independent confirmation. |
| 95 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Risk is also meaningful because the same article describes an early-stage startup with only a $5 million pre-seed raise pursuing an extremely ambitious plan involving an in-orbit demo next year and more than 100,000 orbital data centers, which raises execution and scale risk, although this is supporting article context rather than direct adverse evidence, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
| 96 | Orbital Recovery Crew lowweak | Opp 3 Risk 3 | Thesis: Risk is also material because the evidence is limited to the company's own site and supporting article context, with no independent retained event evidence for contracts, missions, financing, customers, or regulatory outcomes; the same page also conditions service availability on manifest availability and continuing cooperation of regulatory bodies. Why now: The only retained evidence is a page with May 21, 2026, within the 90-day window, indicating recent discoverable claims of operations and service scope, but not a third-party validated catalyst. Evidence
Caveats: Evidence is company-site article context, not independent confirmation. No direct positive or negative dated events are available. Same-article repeated rows are not independent confirmation. |
| 97 | Overview Energy lowweak | Opp 4 Risk 3 | Thesis: The technology area appears highly ambitious and execution-sensitive, but no direct negative evidence is provided in the reviewed sources. Why now: The likely catalyst is the reported Air Force contract, yet the reviewed sources gives no retained article summary or evidence row to establish recency or contract scale. Caveats: Phase2 membership rationale references: but no article summary or evidence are available. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 98 | Pacific Defense lowweak | Opp 4 Risk 3 | Thesis: Despite the favorable context, the reviewed sources contain no post-recent evidence window evidence, no -backed article summary, and no fresh proof of follow-on contracts or operational success after the demo; that limits conviction and leaves execution risk unresolved. Why now: The company appears more advanced than several peers because the reviewed sources references an on-orbit demo under contract, but there is no citable recency signal beyond membership support article ID: and no available evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary for citation. Opportunity score is relative within a weak-evidence batch, not high absolute conviction. |
| 99 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Main risk is evidence opacity and recency uncertainty rather than documented adverse events. The reviewed sources show one article considered but zero article IDs after recent evidence window and zero evidence available after recent evidence window, so business-state visibility is poor. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 100 | Planet Labs PBC lowweak | Opp 3 Risk 3 | Thesis: Risk is moderate because the reviewed sources lack recent direct evidence on contracts, growth, financing, or setbacks, leaving the current business trajectory uncertain. Why now: Why-now is weak: the only in-window evidence is an April 5, 2026 startup-listing article describing Planet as operating its own satellite constellation and geospatial analytics platform, which is durable context but not a clear catalyst. Evidence
Caveats: Evidence is only supporting article context, not direct company event or fact evidence with strong materiality. No direct positive or negative dated events are available. This is a low-conviction watchlist name in these reviewed sources. |